| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 12/13/2001 | WO2001094581A1 Tumour suppressor and uses thereof |
| 12/13/2001 | WO2001094415A2 Nuclear hormone receptor |
| 12/13/2001 | WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | WO2001094391A2 Intracellular signaling proteins |
| 12/13/2001 | WO2001094351A1 Caspase inhibitors and uses thereof |
| 12/13/2001 | WO2001094293A2 Benzamide ligands for the thyroid receptor |
| 12/13/2001 | WO2001093911A2 Macromolecular drug complexes and compositions containing the same |
| 12/13/2001 | WO2001093848A2 Starter kit for low dose oral contraceptives |
| 12/13/2001 | WO2001039742A3 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 12/13/2001 | US20010051646 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 12/13/2001 | US20010051619 E.g., ethyl 3-(4-(2-(3-oxo-2H-1,4-benzoxazin-4-yl)ethoxy)-phenyl-2-ethoxypropenoate where 1,4-benzothiazine or quinoxaline can be substituted for the benzoxazine ring; anticholesterol, diabetic agents; obesity; hyperlimpidemia |
| 12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | CA2411730A1 Tumour suppressor and uses thereof |
| 12/13/2001 | CA2411473A1 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 12/13/2001 | CA2411062A1 Benzamide ligands for the thyroid receptor |
| 12/13/2001 | CA2410993A1 Starter kit for low dose oral contraceptives |
| 12/13/2001 | CA2409392A1 Intracellular signaling proteins |
| 12/13/2001 | CA2409268A1 Macromolecular drug complexes and compositions containing the same |
| 12/13/2001 | CA2409015A1 Caspase inhibitors and uses thereof |
| 12/13/2001 | CA2408748A1 Nuclear hormone receptor |
| 12/12/2001 | EP1162207A1 Amylin agonist peptides and uses therefor |
| 12/12/2001 | EP1161687A1 Grb14 and the insulin receptor and screening of novel medicines |
| 12/12/2001 | EP1161452A2 Covalently bridged insulin dimers |
| 12/12/2001 | EP1161448A1 49 human secreted proteins |
| 12/12/2001 | EP1161444A1 A novel inhibitor of programmed cell death |
| 12/12/2001 | EP1161431A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 12/12/2001 | EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors |
| 12/12/2001 | EP1161418A1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors |
| 12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
| 12/12/2001 | EP1161412A1 Nuclear receptor arylating compounds |
| 12/12/2001 | CN1326459A Heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 12/12/2001 | CN1326456A 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives |
| 12/12/2001 | CN1326353A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 12/12/2001 | CN1326347A 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens |
| 12/12/2001 | CN1326345A Compounds for treatment of estrogen-dependent illnesses and methods for making and using same |
| 12/12/2001 | CN1326343A Agent for lowering prolactin |
| 12/11/2001 | US6329416 Administering to female of child bearing age for 28 consecutive days: first phase dosage of progestational agent; second phase of antiprogesin compound, and third phase of placebo for contraception |
| 12/11/2001 | US6329404 Pharmaceutical composition |
| 12/11/2001 | US6329383 These compounds are useful as a human growth hormone (hgh) mimetic, which trigger gh agonist effects in animals and especially as an orally available human growth hormone (hgh). |
| 12/11/2001 | US6329000 Extract of pine needle and the use thereof |
| 12/11/2001 | US6328977 With neurotoxin |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |
| 12/06/2001 | WO2001092497A2 Human pancreatic islet glucose-6-phosphatase |
| 12/06/2001 | WO2001092485A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE |
| 12/06/2001 | WO2001092308A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | WO2001092304A2 Transporters and ion channels |
| 12/06/2001 | WO2001092292A2 Ghrelin analogs |
| 12/06/2001 | WO2001092221A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 12/06/2001 | WO2001091803A2 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 12/06/2001 | WO2001091787A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | WO2001091782A1 Pralmorelin-containing nasal drop preparations |
| 12/06/2001 | WO2001091751A1 New pharmaceutical composition and the process for its preparation |
| 12/06/2001 | WO2001091744A1 Methods of treating androgen deficiency in men using selective antiestrogens |
| 12/06/2001 | WO2001091724A2 Transdermal delivery of lasofoxifene |
| 12/06/2001 | WO2001091682A1 Composition and applicator for topical substance delivery |
| 12/06/2001 | WO2001049673A3 Compounds and methods for modulation of estrogen receptors |
| 12/06/2001 | WO2001034181A3 Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene |
| 12/06/2001 | WO2001010847A8 Novel integrin receptor antagonists |
| 12/06/2001 | WO2000077233A3 Complement-resistant non-mammalian dna viruses and uses thereof |
| 12/06/2001 | US20010049447 2-(-2-(N-(3-benzoimidazol-2-yl)propyl)-N-methylamino)ethyl)-6-fluoro -1,2,3,4-tetrahydro-1-isopropyl-2-napthyl-esters; antidiabetic agents and treats microvascular or macrovascular diseases associated with diabetes. |
| 12/06/2001 | US20010049360 Betaglycan as an inhibin receptor and uses thereof |
| 12/06/2001 | CA2411667A1 Ghrelin analogs |
| 12/06/2001 | CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | CA2410903A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | CA2410734A1 Dnas encoding mammalian histamine receptor of the h4 subtype |
| 12/06/2001 | CA2410084A1 Transporters and ion channels |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/06/2001 | CA2380769A1 Transdermal delivery of lasofoxifene |
| 12/05/2001 | EP1159965A2 Method of preventing or inhibiting fertilization |
| 12/05/2001 | EP1159457A1 T cell receptor vbeta beta-jbeta) sequence and methods for its detection |
| 12/05/2001 | EP1159418A2 Muc-1 antagonists and methods of treating immune disorders |
| 12/05/2001 | EP1159404A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 12/05/2001 | EP1159292A2 Compounds having growth hormone releasing activity |
| 12/05/2001 | EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta |
| 12/05/2001 | EP1159284A1 33 human secreted proteins |
| 12/05/2001 | EP1159267A1 N-substituted indolines as estrogenic agents |
| 12/05/2001 | EP1159012A1 Encapsulated cells containing an amplified expression vector as a drug delivery device |
| 12/05/2001 | EP1158988A2 Corticosteroid formulation |
| 12/05/2001 | EP0835263B1 Somatostatin peptides |
| 12/05/2001 | EP0445255B2 USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER |
| 12/05/2001 | CN1325408A Compounds with growth hormone releasing propenties |
| 12/05/2001 | CN1325303A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses |
| 12/05/2001 | CN1325302A Use of dialkylfumarates |
| 12/05/2001 | CN1324802A Anti-pregnancy hormone active steroid with fluorated 17 alpha-alkyl-chain |
| 12/05/2001 | CN1075811C Substituted 2,4-thiazolindione derivative, its preparation method and medicinal composition containing same |
| 12/04/2001 | US6326398 Oxamic acids and derivatives as thyroid receptor ligands |
| 12/04/2001 | US6326370 Use of agonists or antagonists of P2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 12/04/2001 | US6326367 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 12/04/2001 | US6326353 123therapy for septic shock; administering polymyxin by injection |
| 12/04/2001 | US6326201 Isolating stem cells of pancreas; obtain pancreatic tissue, dissociate and obtain pancreatic duct tissue, culture, isolate stem cells cells |
| 11/29/2001 | WO2001090359A2 G-protein coupled receptors |
| 11/29/2001 | WO2001090334A2 Drug metabolizing enzymes |
| 11/29/2001 | WO2001090148A2 Neurotransmitter transporters |
| 11/29/2001 | WO2001090137A2 NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11β-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17α-METHOXYMETHYL-17β-METHOXY-ESTRA-4,9-DIEN-3-ONE |
| 11/29/2001 | WO2001090110A1 Macrolides |
| 11/29/2001 | WO2001090094A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090093A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090092A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090091A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |